JD Wetherspoon is raising cash to survive not just closure but low sales after re-opening, as well as plans to snap up cheaper pub sites during the pandemic.
Masdar, a subsidiary of Mubadala Investment Company and a pioneer in sustainable urban development, has partnered with Emirates NBD Asset Management to receive management services for the UAE's first sustainable real estate investment trust – the Masdar Green REIT. Together, Masdar Capital Management (a recently established FSRA Regulated Fund Manager) and Emirates NBD Asset Management bring significant experience and expertise in sustainable real estate and property asset management to the partnership.
It’s a far cry from a normal inauguration, with Washington locked down due to security concerns, and most inaugural events gone virtual because of the raging coronavirus pandemic. A slew of glittery celebrities is descending on Washington — virtually or in person — to welcome the new administration of Joe Biden and Kamala Harris, a duo popular in Hollywood, where Donald Trump was decidedly not.
Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) today announces that the European Commission (EC) has approved an extension of the indication for Doptelet (avatrombopag) to include the treatment of primary chronic immune thrombocytopenia (ITP) in adult patients who are refractory to other treatments (e.g. corticosteroids, immunoglobulins) in all European Union (EU) member states.
The Volvo Group report for the fourth quarter 2020 will be published on February 3, 2021 at 7.20 a.m. CET. There will be a conference call for press and analysts starting at 9.00 a.m. CET.
Mindtree, a leading digital transformation and technology services company, today announced that it has worked with Aflac to develop an enhanced mobile application, called MyAflac Mobile, that enables users to conveniently file claims directly from their mobile device, simplifying the claims process. As policyholders navigate their way through a stressful time due to the global pandemic, Aflac is focused on easing the claims process driven by automated, self-service tools to further improve the user experience and deliver on greater customer centricity.
The England batsman has earned an improved deal in The Hundred.
Making intelligence actionable, Flashpoint charges into 2021 cash flow positive, recording 48% YoY customer growth and delivering over 480% ROI
The proliferating aerospace sector will prominently escalate the sulfone polymers market over the projected timeframe. Additionally, emerging applications of sulfone polymers in the automotive and healthcare sectors owing to their physical strength, clarity, and sterilizing ability are likely to offer new opportunities in the market in the upcoming years, says this report.Selbyville, Delaware, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Based on Global Market Insights Inc., report, the global Sulfone Polymers Market size was estimated at $1.66 billion in 2020 and is slated to surpass $2.3 billion by 2027, registering a CAGR of 4.9% from 2021 to 2027. The report provides a comprehensive analysis of the top winning strategies, wavering industry trends, drivers & opportunities, top investment avenues, competitive scenarios, market estimations & size. Sulfone polymers are gaining higher visibility owing to their multiple benefits including high-temperature resistance characteristics along with the growing demand for replacing metals and glass in a variety of applications such as electrical & electronics, consumer goods, aerospace, automotive, and healthcare. The strong growth in the aerospace, automotive, and healthcare sectors is a major factor driving the overall sulfone polymers industry growth. Request for Sample Report: https://www.gminsights.com/request-sample/detail/1468 In 2020, the polysulfone segment dominated the global sulfone polymers market. Growth is attributed to its wide applications in manufacturing different parts of electronics, automotive, aerospace, and medical devices. Polysulfone possesses excellent properties such as good thermal stability, transparency, toughness & rigidness, and high chemical resistance. Furthermore, the Polyethersulfone (PESU) segment is expected to grow at the fastest pace during the forecast period. PESU is highly suitable for automotive applications, primarily due to its high-temperature resistance and inherent flame-retardant properties. The Polyethersulfone (PESU) segment held a significant share owing to its excellent properties such as temperature resistance and tensile modulus in elasticity. In 2020, the segment accounted for over 33% share and will grow at the highest CAGR of over 5.3% from 2021 – 2027. The electrical and electronics segment is projected to rise significantly with 5.6% CAGR owing to the increasing application of sulfone polymers in switches, battery cases, connectors, & dielectric in semiconductor; coil formers; injection-molded printed circuit boards; plug-and-socket connectors; power circuit breakers parts; power contactors & relays parts; and other electronic components. The growing construction activities in Asia Pacific countries including China, India, Indonesia, and Australia will enhance the demand for adjacent electrical wiring and related products, further boosting the demand for sulfone polymers. Additionally, rising product adoption in the healthcare industry will further influence the overall sulfone polymers market share. Request for customization of this report: https://www.gminsights.com/roc/1468 A stable economy, higher investment in innovation & a greater number of patents, and sophisticated production technology combined with growing consumer demand will be some of the major factors driving the overall sulfone polymers market in North America. The U.S. dominated the regional market due to the increasing production of aircraft and automobiles. Based on the above-mentioned factors, the regional market size will exceed USD 590 million by 2027. Additionally, improving performance of Asia Pacific countries including Japan, India, Australia, and Indonesia in varied sectors will provide a positive outlook for the industry size. The growing demand for innovative products with unique properties suitable for various end-user industries will positively contribute to the overall sulfone polymers industry. Major players, such as BASF and Youju New Materials Co., Ltd., are focusing on the expansion of their production capacities and product portfolio to gain a higher market share. For instance, in 2018, Youju New Materials Co., Ltd. increased its sulfone polymer production capacity to 15,000 MT/year. Additionally, in December 2019, BASF SE expanded its Ultrason P product range with a new polyphenylsulfone-grade Ultrason P2010. About Global Market Insights, Inc. Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider. Offering syndicated and custom research reports, growth consulting, and business intelligence services, Global Market Insights, Inc. aims to help clients with penetrative insights and actionable market data that aid in strategic decision making. GMIPulse, our business analytics platform offers an online, interactive option of exploring our proprietary industry research data in an easy-to-use and dynamic manner. Clients get to explore market intelligence across 11 top-level categories and hundreds of industry segments within them, covering regional, company level and cross-sectional statistics that make our offering a stand-out for decision-makers. CONTACT: Contact Us: Arun Hegde Corporate Sales, USA Global Market Insights, Inc. Phone: 1-302-846-7766 Toll Free: 1-888-689-0688 Email: sales@gminsights.com Web: https://www.gminsights.com
EWM. SA, a Geneva web development and digital marketing agency, is proud to announce the creation of its Paris branch, EWM France, in a joint venture with the OLCM holding company.
The European Patent Office has granted SSH Communications Security Corporation a further patent for PrivX® technology Helsinki, Finland – January 20, 2021 – The European Patent Office (EPO) has granted SSH patent number EP 3495976 on the use of virtual smart cards in temporary certificate-based passwordless access such as the SSH PrivX technology. Passwords are a hassle to use, and they present significant security risks for users and organizations of all sizes, with an average of one in every 250 corporate accounts compromised each month. The World Economic Forum (WEF) estimates that cybercrime costs the global economy $2.9 million every minute, with roughly 80 percent of those attacks directed at passwords. Furthermore, password management is very costly: according to the analyst firm Gartner, up to 20 to 50 percent of all help desk calls are for password resets. The temporary certificate-based access concept used in PrivX removes the need for permanent privileged credentials or passwords altogether, helping customers implement a zero standing privileges (ZSP) strategy through a just-in-time (JIT) model. The invention enables the extremely high security provided by traditional smart card-based authentication without the associated high cost of issuing plastic smart cards, maintaining them, and exchanging credentials. The invention lets enterprises use the existing and widely adopted smart card access infrastructure for PrivX based access, further lowering the cost and effort of implementing PrivX to provide secure access to critical systems, applications, and data. PrivX authenticates users just-in-time based on their roles and entitlements and by using certificates that automatically expire after the authentication is complete. The patented innovation does not leave any standing credentials or passwords behind, and the users never handle or see any secrets. This mitigates the risk of privilege abuse, increases productivity, and reduces the complexity of Privileged Access Management. “We are proud that EPO has further recognized the uniqueness of our PrivX technology and granted this patent,” said Dr. Teemu Tunkelo, CEO of SSH.COM. “The patent validates the uniqueness of our core design choices of PrivX and gives it a sustainable differentiating edge in next-generation Privileged Access Management (PAM) tools. It also aligns well with recognized industry guidelines like Gartner’s zero standing privileges and just-in-time framework and Zero Trust authentication.” SSH.COM has an extensive portfolio of patents or patent applications covering all key products and creates shareholder value by giving SSH.COM both the freedom to operate and significant product differentiation. SSH COMMUNICATIONS SECURITY OYJ Teemu Tunkelo CEO For further information, please contact: Teemu Tunkelo, CEO, tel. +358 40 5499605 Distribution: Nasdaq Helsinki Oy Major media www.ssh.com About SSH Communications Security SSH.COM helps organizations access, secure, and control their digital core – their critical data, applications, and services. We have over 3,000 customers worldwide, including 40 percent of Fortune 500 companies, many of the world's largest financial institutions, and major organizations in all verticals. We are committed to helping our customers thrive in the cloud era with solutions that offer secure access with zero inertia, zero friction, and zero credentials risk. SSH.COM sells online; through offices in North America, Europe, and Asia; and a global network of certified partners. The company's shares (SSH1V) are quoted on the NASDAQ Helsinki. For more information, visit www.ssh.com.
PremiaLab, has today announced the appointment of Mr. Fest as CFO as part of its expansion global expansion. Mr. Fest served as Head of Investment Strategy at Man Group, and held senior positions at Barclays Investment Bank and Mckinsey.
The Smart City Market will grow by USD 2118.14 bn during 2020-2024
Tel Aviv-based global fund manager Liquidity Capital and Dubai-based Vault Investments today announced an agreement to form a joint $100M Venture Debt Investment fund based in Dubai.
JM announces new capacity to produce products that enable 10s of MWs of green hydrogen production
Luxury footwear pioneer Professor Jimmy Choo OBE, today announces the launch of a dynamic new higher education fashion academy in the heart of London, which is on track to become the UK's newest university exclusively dedicated to fashion.
Leading blockchain pioneer HashCash Consultants is to help an Australian organization with its HC NET solution. HashCash's HC NET is to help the enterprise move assets and settle payments facilitating real-time value. Customers of the enterprise can get access to the native digital token - HCX, for conducting digital transactions globally, thereby helping their clients meet their business needs.
Relay & Fio announce the launch of Fionet’s mobile, high-throughput COVID-19 rapid testing solution, for on-site rapid testing in high-volume settingsFionet’s high-throughput modular configuration is capable of processing up to 100 COVID-19 rapid antigen tests per hour with only 2 Fionet devices and 2 personnel, and can easily be scaled into the 1000s per hour with additional devices & personnelThe solution is well positioned to support the growing demand for high-volume testing solutions for airports, sports & entertainment events, workplaces, schools, etc.This solution is designed to turn around tests in as little as 20 minutes and requires a small physical footprint to allow processing at the point of sample collectionA growing body of research demonstrating the feasibility of using rapid antigen tests in airports including recent positive interim results from WestJet-YVR COVID-19 rapid testing study, where “results indicate that a rapid antigen testing approach is feasible for use in departing air travellers.”1 TORONTO, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Relay Medical Corp. (“Relay” or the “Company”) (CSE: RELA, OTC: RYMDF, Frankfurt: EIY2) and Fio Corporation (“Fio”) - together Fionet Rapid Response Group (“FRR”) – announce the launch of its high-throughput COVID-19 rapid testing solution, using its Fionet technology, to administer on-site COVID-19 rapid testing and real-time tracking in high-volume settings like airports, sports & entertainment events, workplaces and schools. Fionet’s high-throughput COVID-19 testing & tracking solution is a complete toolkit enabling rapid testing in high-volume settings using antigen-based rapid diagnostic tests (RDTs). The high-throughput toolkit acts as a “mobile testing lab”, enabling efficient onsite processing of RDTs, data capture and reporting in a variety of community-settings. A single modular processing setup, with optimized workflows, requires two Fionet mobile testing devices, 2 personnel, and tabletop accessories to process up to 100 rapid antigen tests per hour. The flexibility of Fionet allows output to easily be scaled to handle over 1,000 tests per hour with additional devices and personnel, making it a solution for nearly any type of RDT testing program. In addition, the solution is designed to turn around test results in as little as 20 minutes, for minimal wait times and disruptions to travel journeys. “We are extremely excited to launch our Fionet high-throughput rapid testing solution to help support the growing demand for rapid testing in high-volume settings like airports, workplaces and schools. Our solution is designed to be scalable and affordable, both of which are critical to enable a dramatic scale up COVID-19 testing & tracking,” said Dr Michael Greenberg, CEO of Fionet Rapid Response Group and CEO of Fio Corporation. With this solution, FRR is well positioned to capitalize on the growing opportunity for rapid COVID-19 testing solutions in industries that have been crippled by restrictions due to the pandemic. There is growing pressure to ramp up rapid testing capacity at places like airports, cruise ships, arenas, workplaces, and schools. This has become increasingly important with multiple reports of a new, faster spreading COVID-19 variant making its ways around the world. _______________1 Interim Results of the WestJet-YVR COVID-19 Rapid Testing Study “Widespread rapid testing combined with real-time data tracking can be a powerful tool to proactively screen individuals and help prevent transmission so communities can begin to reopen with confidence and ultimately save both lives and livelihoods. There is a growing body of research that has demonstrated how rapid testing can be very useful, even in demanding settings like airports,” said Yoav Raiter, CEO, Relay Medical Corp. Recently, Canada’s top two airlines, Air Canada and WestJet have announced plans to further reduce capacity and headcount, on top of major cuts made last year. Air Canada is cutting an additional 1,700 jobs and will now be operating at just 20% capacity compared to Q1 20192. This is on a backdrop of growing research demonstrating the feasibility of using rapid antigen tests in airports and other high-volume settings to screen travellers for COVID-19. Just this week, positive interim results were published from a WestJet-Vancouver International Airport COVID-19 rapid testing study, reporting that “results indicate that a rapid antigen testing approach is feasible for use in departing air travellers”, “participant feedback was resoundingly positive” and “the research team found that the test itself only takes around 15 to 20 minutes”.1 In addition, the CDC recently issued an order starting Jan 26, 2021, all air passengers arriving to the US from a foreign country to get tested no more than 3 days before their flight departs and to present the negative result or documentation of having recovered from COVID-19 to the airline before boarding the flight. Both NAAT or antigen tests will be accepted.3 SUBSCRIBE: For more information on Relay or to subscribe to the Company’s mail list visit: https://www.relaymedical.com/news _______________2 CBC News: Air Canada cutting about 1,700 jobs as it reduces capacity in response to pandemic restrictions3 CDC Order for COVID-19 testing for all air passengers arriving in US About Relay Medical Corp. Relay Medical is a MedTech innovation Company headquartered in Toronto, Canada focused on the development of novel technologies in the diagnostics and AI data science sectors. Website: www.relaymedical.com About Fio CorporationFio Corporation, privately held and headquartered in Toronto, developed and markets the world’s first integrated guidance & tracking IT platform for decentralized healthcare settings, a new category of solution that raises healthcare quality and lowers healthcare costs. The platform enables average healthcare workers in clinics to deliver a new level of quality-controlled diagnostic testing and case management. Simultaneously, as an automated by-product of its clinical use, the platform captures and provides unprecedented frontline data to remote supervisors and stakeholders, enabling real-time remote tracking, insight distribution, and intervention. Fio operates globally in partnership with local distribution, service, and support organizations and also partners with other companies that license its technologies. Website: www.fio.comContact:W. Clark KentPresidentRelay Medical Corp.Office. 647-872-9982 ext. 2TF. 1-844-247-6633 ext. 2investor.relations@relaymedical.comBernhard LangerEU Investor RelationsOffice. +49 (0) 177 774 2314Email: blanger@relaymedical.com Forward-looking Information Cautionary Statement Except for statements of historic fact, this news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including, but not limited to delays or uncertainties with regulatory approvals, including that of the CSE. There are uncertainties inherent in forward-looking information, including factors beyond the Company’s control. There are no assurances that the commercialization plans for the technology described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management's estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company’s filings with Canadian securities regulators, which filings are available at www.sedar.com
Live news and updates
"The milk in my fridge will now outlast the Trump Presidency," wrote one Twitter user.